首页> 外文会议>International conference on applied biotechnology >Pharmacophore-Based Virtual Screening and Result Analysis of Histone Methyltransferase SMYD3 Inhibitors
【24h】

Pharmacophore-Based Virtual Screening and Result Analysis of Histone Methyltransferase SMYD3 Inhibitors

机译:基于药物的虚拟筛选和组蛋白甲基转移酶SMYD3抑制剂的效果分析

获取原文

摘要

Histone methyltransferase SMYD3 is a kind of protease relating to different kinds of tumors, which makes it a promising target for anticancer drugs. In order to find new small molecule inhibitors of SMYD3 for oncotherapy, a phar-macophore was created based on the crystal structure of SMYD3 with sinefungin (SFG) from Protein Data Bank (PDB ID: 3PDN) by using the software of Ligand Scout 3.1. The virtual screening of ZINC database was conducted with the phar-macophore using MOE software. Two hundred and four hits which meet at least five pharmacophore characteristics were obtained and four structural characteristics were summarized from these hits, which have laid a data foundation for the discovery of novel SMYD3 inhibitors.
机译:组蛋白甲基转移酶Smyd3是一种与不同种类的肿瘤有关的蛋白酶,这使其成为抗癌药物的有希望的靶标。为了找到用于哺乳治疗的新型Smyd3的小分子抑制剂,通过使用配体侦察3.1的软件,基于来自蛋白质数据库(PDB ID:3PDN)的Sinefungin(SFG)的Smyd3的Smyd3的晶体结构来产生法律 - 大麦。使用Moe软件与Phar-MACOLOLE进行ZINC数据库的虚拟屏幕。获得至少五种药物团特征的二百四次命中,并从这些命中总结了四种结构特征,为发现新型SMYD3抑制剂奠定了数据基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号